• Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

    12 days ago - By Xconomy

    Startup nference has closed a $60 million Series B financing round to expand the use of its augmented intelligence platform in clinical research and drug development. Mayo Clinic and NTT Venture Capital joined previous investors Matrix Partners and Matrix Capital Management, which participated in the Cambridge, MA-based company's Series A round in 2018. The relationship with Mayo Clinic is not new, however, as the research group in 2017 launched a startup with nference-dubbed Qrativ-to help match drugs with diseases they might be able to treat. Also familiar faces, Matrix Capital...
    Read more ...